Heinz Subsidiary Signs Infant Formula License Agreement With Martek
Columbia, MD-based Martek Biosciences Corporation has signed a non exclusive agreement with Heinz Wattie’s Limited, Hastings, New Zealand, for Martek’s technology relating to the use of long chain polyunsaturated fatty acids in infant formula. The agreement provides for initial cash payments and would give Martek an ongoing royalty upon Heinz’s introduction of products using Martek’s technology for doco­sahexaenoic acid (DHA) and arachidonic acid (ARA). The license covers Australia, New Zealand and certain Pacific island